Across TCGA pan-cancer cohorts, COPS8 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated COPS8 data layer compared with 24 for mass-spec protein and 2 for mutation status.
The strongest signal is observed in lung adenocarcinoma (LUAD), where higher COPS8 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated COPS8 expression acts as an unfavorable survival marker, although some lineages such as CCRCC and UCEC show a favorable association.
LUAD, CCRCC, and UCEC are the cancer types where COPS8 mass-spec protein most reproducibly stratifies survival.